| scholarly article | Q13442814 |
| P50 | author | Heike Hofmann | Q27674369 |
| Mindy S Kurzer | Q89560980 | ||
| P2093 | author name string | Kenneth J Koehler | |
| Marta D Van Loan | |||
| D Lee Alekel | |||
| Laura N Hanson | |||
| Ulrike Genschel | |||
| Charles T Peterson | |||
| Bonnie S Beer | |||
| P2860 | cites work | What is meant by intention to treat analysis? Survey of published randomised controlled trials | Q24647858 |
| Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165] | Q24794752 | ||
| Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. | Q30859481 | ||
| Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women | Q30914141 | ||
| Updated data on proximal femur bone mineral levels of US adults | Q31956442 | ||
| Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women | Q34492996 | ||
| Alcohol consumption and endometrial cancer: some unresolved issues | Q35147506 | ||
| Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study | Q35880965 | ||
| A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations | Q37423414 | ||
| The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women | Q37474722 | ||
| Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial | Q38486654 | ||
| Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment | Q39422045 | ||
| Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study | Q39428202 | ||
| Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial | Q40561102 | ||
| Long-term endometrial and breast safety of a specific, standardized soy extract | Q43104714 | ||
| Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial | Q43112926 | ||
| Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study | Q43658789 | ||
| Benefits of soy isoflavone therapeutic regimen on menopausal symptoms | Q43895023 | ||
| Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women | Q43959355 | ||
| Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries | Q44435016 | ||
| Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study | Q46228428 | ||
| Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women | Q46683955 | ||
| Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer | Q46926909 | ||
| A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 | ||
| Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition | Q57054433 | ||
| Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study | Q61852148 | ||
| Modest hormonal effects of soy isoflavones in postmenopausal women | Q66829473 | ||
| International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives | Q77731138 | ||
| Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults | Q77764633 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 185-197 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Menopause | Q6817295 |
| P1476 | title | Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women | |
| P478 | volume | 22 |
| Q55421480 | 8-Prenylgenistein, a prenylated genistein derivative, exerted tissue selective osteoprotective effects in ovariectomized mice. |
| Q36038982 | Characterization of β-glucosidase from Aspergillus terreus and its application in the hydrolysis of soybean isoflavones |
| Q33772887 | Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms |
| Q39948038 | Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints |
| Q58726869 | Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation |
| Q89347304 | Nutritional prevention of cognitive decline and dementia |
| Q35953705 | Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials |
| Q47157326 | Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones |
| Q51281147 | Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled Trial. |
| Q28071946 | Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature |
| Q86425926 | The association between soya consumption and serum thyroid-stimulating hormone concentrations in the Adventist Health Study-2 |
Search more.